2010
DOI: 10.1038/onc.2009.496
|View full text |Cite
|
Sign up to set email alerts
|

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase

Abstract: Wnt5a is a representative ligand that activates the b-catenin-independent pathway in Wnt signaling. Although it has been reported that abnormal activation of the Wnt/ b-catenin-dependent pathway is often observed in human prostate cancer, the involvement of the b-catenin-independent pathway in this cancer is unclear. Abnormal expression of Wnt5a and b-catenin was observed in 27 (28%) and 49 (50%) of 98 prostate cancer cases, respectively, by immunohistochemical analyses. Simultaneous expression of Wnt5a and b-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
197
3

Year Published

2010
2010
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 197 publications
(211 citation statements)
references
References 47 publications
(65 reference statements)
11
197
3
Order By: Relevance
“…These results are also supported by recent studies demonstrating that hydrogen peroxide-mediated proliferation is due to binding of Fra-1/JunD and phospho-c-Jun to the HARP promoter sites (57). JunD was also reported to be involved in migration and invasion of prostate cancer cells by inducing the expression of metalloproteinase-1-mediated by the Wnt5a signaling pathway (72). Interestingly, this action of JunD on prostate cancer cell migration was reported to be opposite to the effect of JunB and c-Jun (73).…”
Section: Figure 6 Tgf-␤1 Did Not Induce Jund or Sapk/jnk Phosphorylasupporting
confidence: 81%
“…These results are also supported by recent studies demonstrating that hydrogen peroxide-mediated proliferation is due to binding of Fra-1/JunD and phospho-c-Jun to the HARP promoter sites (57). JunD was also reported to be involved in migration and invasion of prostate cancer cells by inducing the expression of metalloproteinase-1-mediated by the Wnt5a signaling pathway (72). Interestingly, this action of JunD on prostate cancer cell migration was reported to be opposite to the effect of JunB and c-Jun (73).…”
Section: Figure 6 Tgf-␤1 Did Not Induce Jund or Sapk/jnk Phosphorylasupporting
confidence: 81%
“…The latest induced cytoskeleton reorganization and increased cell motility 82 . In this sense, overexpression of Wnt5a in human prostate cancer cell lines stimulated their invasion activities 83 . Abnormal expression of Wnt5a was also observed in 28% of prostate cancer by immunohistochemistry and positivity was correlated with high Gleason scores and biochemical relapse of prostate cancer.…”
Section: Wnt Signaling Abnormalities In Human Prostate Cancermentioning
confidence: 99%
“…10,11 The presence of Wnt ligands can enhance the binding of b-catenin to androgen receptor (AR) and promote AR-mediated transcription. 35 Others suggested that IL-6 might modulate the AR nuclear transactivation via STAT3, MAPK, or other signaling cascades. 36,37 In MSCs, activation of phosphorylation of the STAT-3 and MAPK signaling cascades was detected after treatment with either IL-6 or its soluble receptor sIL-6R (Supporting Fig.…”
Section: Discussionmentioning
confidence: 99%